- AU$482.54m
- AU$418.53m
- AU$336.37m
- 74
- 76
- 74
- 87
Annual income statement for Lycopodium, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 159 | 229 | 326 | 348 | 336 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 141 | 192 | 265 | 281 | 281 |
Operating Profit | 17.6 | 37.1 | 60.4 | 67.4 | 55.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 21.5 | 38.9 | 63.3 | 69.7 | 60.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 14.1 | 26.9 | 45.6 | 50.9 | 42.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 14.2 | 27.2 | 46.8 | 50.7 | 42.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 14.2 | 27.2 | 46.8 | 50.7 | 42.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.355 | 0.684 | 1.18 | 1.28 | 1.06 |
Dividends per Share |